Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease

This study has been completed.
Sponsor:
Collaborators:
Weill Medical College of Cornell University
North Shore University Hospital
Information provided by:
Neurologix, Inc.
ClinicalTrials.gov Identifier:
NCT00195143
First received: September 15, 2005
Last updated: March 26, 2008
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given
No publications provided by Neurologix, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):